FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208388526> ?p ?o ?g. }

• W3208388526 endingPage "1708" @default.
• W3208388526 startingPage "1702" @default.
• W3208388526 abstract "Aims Intra-articular administration of antibiotics during primary total knee arthroplasty (TKA) may represent a safe, cost-effective strategy to reduce the risk of acute periprosthetic joint infection (PJI). Vancomycin with an aminoglycoside provides antimicrobial cover for most organisms isolated from acute PJI after TKA. However, the intra-articular doses required to achieve sustained therapeutic intra-articular levels while remaining below toxic serum levels is unknown. The purpose of this study is to determine the intra-articular and serum levels of vancomycin and tobramycin over the first 24 hours postoperatively after intra-articular administration in primary cementless TKA. Methods A prospective cohort study was performed. Patients were excluded if they had poor renal function, known allergic reaction to vancomycin or tobramycin, received intravenous vancomycin, or were scheduled for same-day discharge. All patients received 600 mg tobramycin and 1 g of vancomycin powder suspended in 25 cc of normal saline and injected into the joint after closure of the arthrotomy. Serum from peripheral venous blood and drain fluid samples were collected at one, four, and 24 hours postoperatively. All concentrations are reported in µg per ml. Results A total of 22 patients were included in final analysis. At one, four, and 24 hours postoperatively, mean (95% confidence interval (CI)) serum concentrations were 2.4 (0.7 to 4.1), 5.0 (3.1 to 6.9), and 4.8 (2.8 to 6.9) for vancomycin and 4.9 (3.4 to 6.3), 7.0 (5.8 to 8.2), and 1.3 (0.8 to 1.8) for tobramycin; intra-articular concentrations were 1,900.6 (1,492.5 to 2,308.8), 717.9 (485.5 to 950.3), and 162.2 (20.5 to 304.0) for vancomycin and 2,105.3 (1,389.9 to 2,820.6), 403.2 (266.6 to 539.7), and 98.8 (0 to 206.5) for tobramycin. Conclusion Intra-articular administration of 1 g of vancomycin and 600 mg of tobramycin as a solution after closure of the arthrotomy in primary cementless TKA achieves therapeutic intra-articular concentrations over the first 24 hours postoperatively and does not reach sustained toxic levels in peripheral blood. Cite this article: Bone Joint J 2021;103-B(11):1702–1708." @default.
• W3208388526 created "2021-11-08" @default.
• W3208388526 creator A5015288124 @default.
• W3208388526 creator A5044520292 @default.
• W3208388526 creator A5047088006 @default.
• W3208388526 creator A5058183848 @default.
• W3208388526 creator A5090574189 @default.
• W3208388526 date "2021-11-01" @default.
• W3208388526 modified "2023-10-06" @default.
• W3208388526 title "Intra-articular administration of vancomycin and tobramycin during primary cementless total knee arthroplasty" @default.
• W3208388526 cites W1860679254 @default.
• W3208388526 cites W1892779545 @default.
• W3208388526 cites W1970021530 @default.
• W3208388526 cites W2000588613 @default.
• W3208388526 cites W2015774835 @default.
• W3208388526 cites W2051787900 @default.
• W3208388526 cites W2059536321 @default.
• W3208388526 cites W2068148547 @default.
• W3208388526 cites W2140147718 @default.
• W3208388526 cites W2159227531 @default.
• W3208388526 cites W2212259890 @default.
• W3208388526 cites W2275041593 @default.
• W3208388526 cites W2318220516 @default.
• W3208388526 cites W2488707854 @default.
• W3208388526 cites W2550348418 @default.
• W3208388526 cites W2610895230 @default.
• W3208388526 cites W2620769769 @default.
• W3208388526 cites W2763776786 @default.
• W3208388526 cites W2773634534 @default.
• W3208388526 cites W2887740967 @default.
• W3208388526 cites W2889848104 @default.
• W3208388526 cites W2900179074 @default.
• W3208388526 cites W2937933905 @default.
• W3208388526 cites W2941366030 @default.
• W3208388526 cites W2973663104 @default.
• W3208388526 cites W2984297095 @default.
• W3208388526 cites W2993438840 @default.
• W3208388526 cites W3014813855 @default.
• W3208388526 cites W3028289311 @default.
• W3208388526 cites W3030013242 @default.
• W3208388526 cites W3046413552 @default.
• W3208388526 cites W3046715926 @default.
• W3208388526 cites W3091180359 @default.
• W3208388526 cites W3096830483 @default.
• W3208388526 cites W3110327721 @default.
• W3208388526 doi "https://doi.org/10.1302/0301-620x.103b11.bjj-2020-2453.r1" @default.
• W3208388526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34719272" @default.
• W3208388526 hasPublicationYear "2021" @default.
• W3208388526 type Work @default.
• W3208388526 sameAs 3208388526 @default.
• W3208388526 citedByCount "5" @default.
• W3208388526 countsByYear W32083885262022 @default.
• W3208388526 countsByYear W32083885262023 @default.
• W3208388526 crossrefType "journal-article" @default.
• W3208388526 hasAuthorship W3208388526A5015288124 @default.
• W3208388526 hasAuthorship W3208388526A5044520292 @default.
• W3208388526 hasAuthorship W3208388526A5047088006 @default.
• W3208388526 hasAuthorship W3208388526A5058183848 @default.
• W3208388526 hasAuthorship W3208388526A5090574189 @default.
• W3208388526 hasConcept C141071460 @default.
• W3208388526 hasConcept C2775832221 @default.
• W3208388526 hasConcept C2777160814 @default.
• W3208388526 hasConcept C2777787772 @default.
• W3208388526 hasConcept C2778120723 @default.
• W3208388526 hasConcept C2778336525 @default.
• W3208388526 hasConcept C2778974779 @default.
• W3208388526 hasConcept C2778980435 @default.
• W3208388526 hasConcept C2779162959 @default.
• W3208388526 hasConcept C2779489039 @default.
• W3208388526 hasConcept C42219234 @default.
• W3208388526 hasConcept C501593827 @default.
• W3208388526 hasConcept C523546767 @default.
• W3208388526 hasConcept C54355233 @default.
• W3208388526 hasConcept C71924100 @default.
• W3208388526 hasConcept C86803240 @default.
• W3208388526 hasConcept C89423630 @default.
• W3208388526 hasConceptScore W3208388526C141071460 @default.
• W3208388526 hasConceptScore W3208388526C2775832221 @default.
• W3208388526 hasConceptScore W3208388526C2777160814 @default.
• W3208388526 hasConceptScore W3208388526C2777787772 @default.
• W3208388526 hasConceptScore W3208388526C2778120723 @default.
• W3208388526 hasConceptScore W3208388526C2778336525 @default.
• W3208388526 hasConceptScore W3208388526C2778974779 @default.
• W3208388526 hasConceptScore W3208388526C2778980435 @default.
• W3208388526 hasConceptScore W3208388526C2779162959 @default.
• W3208388526 hasConceptScore W3208388526C2779489039 @default.
• W3208388526 hasConceptScore W3208388526C42219234 @default.
• W3208388526 hasConceptScore W3208388526C501593827 @default.
• W3208388526 hasConceptScore W3208388526C523546767 @default.
• W3208388526 hasConceptScore W3208388526C54355233 @default.
• W3208388526 hasConceptScore W3208388526C71924100 @default.
• W3208388526 hasConceptScore W3208388526C86803240 @default.
• W3208388526 hasConceptScore W3208388526C89423630 @default.
• W3208388526 hasIssue "11" @default.
• W3208388526 hasLocation W32083885261 @default.
• W3208388526 hasLocation W32083885262 @default.
• W3208388526 hasOpenAccess W3208388526 @default.
• W3208388526 hasPrimaryLocation W32083885261 @default.

• next